Last reviewed · How we verify
Placebo 0% Lotion
Placebo 0% Lotion contains no active pharmaceutical ingredient and produces therapeutic effects solely through placebo response mechanisms.
At a glance
| Generic name | Placebo 0% Lotion |
|---|---|
| Sponsor | Mayne Pharma International Pty Ltd |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo formulation, this lotion lacks any active drug substance and relies on the patient's expectation and psychological response to treatment. The therapeutic benefit, if any, derives from placebo effect rather than pharmacological action. This formulation is typically used in clinical trials as a control comparator to assess the true efficacy of active treatments.
Approved indications
Common side effects
Key clinical trials
- ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis (PHASE1)
- A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks (PHASE3)
- A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris (PHASE3)
- Bioequivalence Study for Benzyl Alcohol Lotion 5%. (PHASE3)
- A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo 0% Lotion CI brief — competitive landscape report
- Placebo 0% Lotion updates RSS · CI watch RSS
- Mayne Pharma International Pty Ltd portfolio CI